EORTC-62931-STBSG

Back to Clinical Trials Database

Randomized phase III trial of adjuvant chemotherapy with high-dose doxorubicin, ifosfamide and lenograstim in high grade soft tissue sarcoma.

Study documentation

Trial Status	All trial activities ended
Dates	Date of activation: 08-Feb-1995 Date Step1 close: 15-Dec-2003
Data management at EORTC	Yes
Design	Phase 3 Randomized open label
Targeted Sample size	EORTC Groups: 340
Treatment	Radiotherapy, Drug
Study Staff
Type of cancer	Soft Tissue and Bone Sarcoma
Participating groups	EORTC Soft Tissue and Bone Sarcoma Group NCIC Clinical Trial Group Schweizerisches Arbeitsgemeinschaft Klin. Krebsforschung Canadian Sarcoma Group
Centers to be activated	Centre Leon Berard (Lyon, France) Erasmus MC (Rotterdam, Netherlands) Gustave Roussy (VILLEJUIF CEDEX, France) Hopital Universitaires Erasme (Brussels, Belgium) Hospital De La Santa Creu I Sant Pau (Barcelona, Spain) IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy) Institut Jules Bordet (Anderlecht, Belgium) Instituto Portugues de Oncologia de Lisboa Francisco Gentil – EPE (Lisboa, Portugal) Istituto Clinico Humanitas (Rozzano, Milano, Italy) Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Medical University of Graz (Graz, Austria) Narodny Onkologicky Ustav - Bratislava (Bratislava, Slovakia) Newcastle Hospitals NHS Trust - Campus for Ageing and Vitality (Newcastle-Upon-Tyne, United Kingdom) Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom) Royal Marsden Hospital - Chelsea, London (London, United Kingdom) The Christie NHS Foundation Trust (Manchester, United Kingdom) Universitaetsklinikum - Essen (Essen, Germany) Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center (Hamburg, Germany) Universitaetsklinikum Tuebingen-Uni Kliniken Berg (Tuebingen, Germany) Universitair Ziekenhuis Antwerpen (Edegem, Belgium) University College Hospital (London, United Kingdom) University Medical Center Groningen (Groningen, Netherlands)
Protocol summary	http://clinicaltrials.gov/study/NCT00002641
NCT number	NCT00002641
Financial Support	EORTC HQ